RxDoctor Payments Data

Donna Stockton-Rodriguez, MD

Dermatology · Mokena, ILNPI 1851386221

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,425 and has fallen 64.4% since, to $508 in 2025.

$7,496in general payments, 2019–2025

Across 369 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Merz North America, Inc.$599
  • VYNE Pharmaceuticals Inc.$578
  • Sun Pharmaceutical Industries Inc.$531
  • Regeneron Healthcare Solutions, Inc.$510
  • Pfizer$448
  • plus $4K from 27 others
$23,501in research payments, 2019–2025

Across 48 payments — averaging $489.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$24K

What the payments were for

  • Food & beverage$7,31098%
  • Education$1862%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,496 in reported general payments places this provider in the 75th percentile of 606 dermatology providers in Illinois.

See all dermatology providers in Illinois →

Medicare billing

Part B allowed, 2024
$107,035
Medicare patients
312
Services billed
1,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate22$1,144
Fluocinonide32$1,128
Ciclopirox12$378
Ketoconazole11$205
MethotrexateMethotrexate Sodium22$199
Doxycycline Hyclate12$183

Paid to pharmacies, not to this prescriber.

Other dermatology in Mokena

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →